Bone Biologics Corp (BBLG):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Bone Biologics Corp (BBLG) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6556
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bone Biologics Corp (Bone Biologics) is a biotechnology company that develops orthobiologic products. The company develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers Nell-1/TCP fusion device, which is a single dose vial of Nell-1 recombinant protein freeze dried onto tricalcium phosphate and demineralized bone putty. The company’s technology has application in spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicines. It collaborates with manufacturing organizations to develop its products. The company markets its products domestic and internationally. Bone Biologics is headquartered in Burlington, Massachusetts, the US.

Bone Biologics Corp (BBLG) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bone Biologics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Bone Biologics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bone Biologics Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Bone Biologics Raises USD5.75 Million in Venture Financing 10
Bone Biologics Raises USD5 Million in Venture Financing 11
Partnerships 12
Bone Biologics Enters into Option Agreement with UCLA 12
Merger 13
AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction 13
Equity Offering 14
Bone Biologics Raises USD3.9 Million in Private Placement of Shares 14
Bone Biologics Raises USD0.5 million in Second Tranche of Financing 15
Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of Shares 16
Debt Offering 17
Bone Biologics Raises USD2 Million in Private Placement of 8.5% Notes Due 2019 17
Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of 8.5% Convertible Promissory Note Due 2017 18
Bone Biologics Corp – Key Competitors 19
Bone Biologics Corp – Key Employees 20
Bone Biologics Corp – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Aug 03, 2017: Bone Biologics Announces Appointment of Bret Hankey to Company’s Board of Director 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Bone Biologics Corp, Medical Equipment, Key Facts, 2017 2
Bone Biologics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bone Biologics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Bone Biologics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Deals By Market, 2012 to YTD 2018 8
Bone Biologics Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bone Biologics Raises USD5.75 Million in Venture Financing 10
Bone Biologics Raises USD5 Million in Venture Financing 11
Bone Biologics Enters into Option Agreement with UCLA 12
AFH Acquisition Merges with Bone Biologics in Reverse Merger Transaction 13
Bone Biologics Raises USD3.9 Million in Private Placement of Shares 14
Bone Biologics Raises USD0.5 million in Second Tranche of Financing 15
Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of Shares 16
Bone Biologics Raises USD2 Million in Private Placement of 8.5% Notes Due 2019 17
Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of 8.5% Convertible Promissory Note Due 2017 18
Bone Biologics Corp, Key Competitors 19
Bone Biologics Corp, Key Employees 20

List of Figures
Bone Biologics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bone Biologics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bone Biologics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bone Biologics Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bone Biologics Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bone Biologics Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Bone Biologics Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bone Biologics Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Bone Biologics Corp (BBLG):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SK Bioland Co Ltd:企業の戦略・SWOT・財務情報
    SK Bioland Co Ltd - Strategy, SWOT and Corporate Finance Report Summary SK Bioland Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Industrias Metalurgicas Pescarmona SA:企業の戦略的SWOT分析
    Industrias Metalurgicas Pescarmona SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Frontage Laboratories Inc-製薬・医療分野:企業M&A・提携分析
    Summary Frontage Laboratories Inc (Frontage), a subsidiary of Hangzhou Tigermed Consulting Co Ltd is a contract research organization that offers early phase drug development and other research services. The organization’s services include clinical research, drug metabolism and pharmacokinetic, CMC …
  • Mount Gibson Iron Ltd:企業の戦略・SWOT・財務情報
    Mount Gibson Iron Ltd - Strategy, SWOT and Corporate Finance Report Summary Mount Gibson Iron Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pangaea Biotech SL:企業の製品パイプライン分析2018
    Summary Pangaea Biotech SL (Pangaea) is a provider of molecular diagnostics and research and development services for cancer treatment. The company discovers and develops gene signatures and prognostic markers. Its services include molecular diagnosis, in vitro drug testing, clinical trials, biomark …
  • Vanguard Natural Resources Inc (VNRR):石油・ガス:M&Aディール及び事業提携情報
    Summary Vanguard Natural Resources, Inc (Vanguard) is an independent oil and gas company with upstream operations. It acquires, produces, and develops oil and natural gas properties. The company owns producing and non-producing oil and natural gas assets in the Green River Basin in Wyoming; the Perm …
  • Berthold Technologies GmbH & Co. KG:企業の戦略的SWOT分析
    Berthold Technologies GmbH & Co. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Lexicon Pharmaceuticals Inc (LXRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Lexicon Pharmaceuticals Inc (Lexicon) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of innovative treatments for human diseases. The company has advanced multiple drug candidates into clinical development and has clinical-stage drug program …
  • Armed Forces Insurance:企業の戦略的SWOT分析
    Armed Forces Insurance - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Infinite Group Inc (IMCI):企業の財務・戦略的SWOT分析
    Summary Infinite Group Inc (IGI) is a technology company that offers IT service and support solutions virtualization and cybersecurity. The company offers Nodeware, an automated network vulnerability management system that assesses vulnerabilities in a computer network using scanning technology. Its …
  • AGL Energy Ltd (AGL):石油・ガス:M&Aディール及び事業提携情報
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • Getac Technology Corporation:企業の戦略・SWOT・財務情報
    Getac Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary Getac Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Prolung Inc (LUNG):医療機器:M&Aディール及び事業提携情報
    Summary Prolung Inc(Prolung) formerly known as Fresh Medical Laboratories Inc, is a medical device company that offers diagnostic services. The company offers electro pulmonary nodule scanner system used for the non invasive early diagnostics of different types of diseases. Its EPN system consists o …
  • Cardiovascular Systems Inc (CSII):企業の財務・戦略的SWOT分析
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accesso …
  • MOIL Ltd:企業の戦略・SWOT・財務分析
    MOIL Ltd - Strategy, SWOT and Corporate Finance Report Summary MOIL Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Multiplan Empreendimentos Imobiliarios SA:企業の戦略・SWOT・財務情報
    Multiplan Empreendimentos Imobiliarios SA - Strategy, SWOT and Corporate Finance Report Summary Multiplan Empreendimentos Imobiliarios SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Willis Towers Watson Public Ltd Co:戦略・SWOT・企業財務分析
    Willis Towers Watson Public Ltd Co - Strategy, SWOT and Corporate Finance Report Summary Willis Towers Watson Public Ltd Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Mediclin AG (MED):企業の財務・戦略的SWOT分析
    Summary Mediclin AG (Mediclin) is a healthcare service provider that provides rehabilitation and medical care services. The center provides services in neuro-medicine with neurology, early neurological rehabilitation, neurosurgery and neuroradiology and psychological sciences, among others. It also …
  • Karolinska Institute-医療機器分野:企業M&A・提携分析
    Summary Karolinska Institutet (KI) is a medical university that offers education services. The university provides education and research in the fields of medicine and health sciences. Its education courses include audiology, biomedicine, biomedical lab science, dental hygiene, medicine, nursing, oc …
  • Banner Health:企業の戦略的SWOT分析
    Banner Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆